Cellectar Biosciences Return on Tangible Equity 2010-2025 | CLRB
Current and historical return on tangible equity values for Cellectar Biosciences (CLRB) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Cellectar Biosciences Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $-0.03B | $0.01B | -204.08% |
| 2024-12-31 | $-0.05B | $0.01B | -333.33% |
| 2024-09-30 | $-0.05B | $0.02B | -816.00% |
| 2024-06-30 | $-0.05B | $0.01B | 7200.00% |
| 2024-03-31 | $-0.06B | $0.01B | 1680.00% |
| 2023-12-31 | $-0.04B | $-0.02B | 819.05% |
| 2023-09-30 | $-0.05B | $-0.01B | -9000.00% |
| 2023-06-30 | $-0.04B | $0.00B | -500.00% |
| 2023-03-31 | $-0.03B | $0.01B | -266.67% |
| 2022-12-31 | $-0.03B | $0.01B | -182.35% |
| 2022-09-30 | $-0.03B | $0.01B | -116.13% |
| 2022-06-30 | $-0.03B | $0.02B | -84.03% |
| 2022-03-31 | $-0.02B | $0.03B | -67.13% |
| 2021-12-31 | $-0.02B | $0.03B | -57.83% |
| 2021-09-30 | $-0.02B | $0.04B | -46.81% |
| 2021-06-30 | $-0.02B | $0.04B | -48.48% |
| 2021-03-31 | $-0.02B | $0.05B | -51.06% |
| 2020-12-31 | $-0.02B | $0.06B | -66.67% |
| 2020-09-30 | $-0.02B | $0.02B | -120.00% |
| 2020-06-30 | $-0.02B | $0.02B | -130.43% |
| 2020-03-31 | $-0.01B | $0.01B | -133.33% |
| 2019-12-31 | $-0.01B | $0.01B | -119.15% |
| 2019-09-30 | $-0.02B | $0.01B | -117.65% |
| 2019-06-30 | $-0.02B | $0.02B | -118.52% |
| 2019-03-31 | $-0.02B | $0.01B | -156.10% |
| 2018-12-31 | $-0.02B | $0.01B | -162.16% |
| 2018-09-30 | $-0.02B | $0.02B | -206.06% |
| 2018-06-30 | $-0.02B | $0.00B | -250.00% |
| 2018-03-31 | $-0.02B | $0.01B | -200.00% |
| 2017-12-31 | $-0.02B | $0.01B | -166.67% |
| 2017-09-30 | $-0.02B | $0.01B | -153.85% |
| 2017-06-30 | $-0.01B | $0.01B | -143.59% |
| 2017-03-31 | $-0.01B | $0.01B | -136.84% |
| 2016-12-31 | $-0.01B | $0.01B | -133.33% |
| 2016-09-30 | $0.00B | $0.01B | -53.33% |
| 2016-06-30 | $0.00B | $0.01B | -100.00% |
| 2016-03-31 | $0.00B | $0.00B | -800.00% |
| 2015-12-31 | $-0.01B | $0.00B | -666.67% |
| 2015-09-30 | $-0.01B | $0.00B | -450.00% |
| 2015-06-30 | $-0.01B | $0.00B | -140.00% |
| 2015-03-31 | $-0.01B | $0.00B | -186.67% |
| 2014-12-31 | $-0.01B | $0.01B | -320.00% |
| 2014-09-30 | $-0.01B | $0.01B | -720.00% |
| 2014-06-30 | $-0.01B | $0.00B | 1333.33% |
| 2014-03-31 | $-0.01B | $0.00B | -800.00% |
| 2013-12-31 | $-0.01B | $0.00B | -333.33% |
| 2013-09-30 | $-0.01B | $0.00B | -160.00% |
| 2013-06-30 | $-0.01B | $0.00B | -166.67% |
| 2013-03-31 | $-0.01B | $0.01B | -137.93% |
| 2012-12-31 | $-0.01B | $0.01B | -120.00% |
| 2012-09-30 | $-0.01B | $0.01B | -120.00% |
| 2012-06-30 | $-0.01B | $0.01B | -110.34% |
| 2012-03-31 | $-0.01B | $0.01B | -133.33% |
| 2011-12-31 | $-0.01B | $0.01B | -152.38% |
| 2011-09-30 | $-0.01B | $0.01B | -184.62% |
| 2011-06-30 | $-0.01B | $0.01B | -500.00% |
| 2011-03-31 | $0.00B | $0.00B | 320.00% |
| 2010-12-31 | $0.00B | $0.00B | -160.00% |
| 2010-09-30 | $-0.01B | $0.00B | 338.46% |
| 2010-06-30 | $-0.01B | $0.00B | 433.33% |
| 2010-03-31 | $-0.02B | $0.00B | 457.14% |
| 2009-12-31 | $-0.02B | $-0.01B | 766.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.012B | $0.000B |
| Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.007B | 27.90 |
| Boston Scientific (BSX) | United States | $155.135B | 38.84 |
| Stryker (SYK) | United States | $149.698B | 31.30 |
| EssilorLuxottica (ESLOY) | France | $129.877B | 0.00 |
| Medtronic (MDT) | Ireland | $110.440B | 16.12 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.984B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.101B | 27.36 |
| ResMed (RMD) | United States | $36.449B | 27.38 |
| GE HealthCare Technologies (GEHC) | United States | $33.384B | 15.85 |
| Agilent Technologies (A) | United States | $32.046B | 21.17 |
| Terumo (TRUMY) | Japan | $27.153B | 35.27 |
| Koninklijke Philips (PHG) | Netherlands | $22.822B | 16.41 |
| Insulet (PODD) | United States | $22.662B | 88.96 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.138B | 12.29 |
| Baxter (BAX) | United States | $15.929B | 11.89 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.591B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.618B | 23.03 |
| Lantheus Holdings (LNTH) | United States | $5.520B | 13.92 |
| Prestige Consumer Healthcare (PBH) | United States | $4.305B | 19.23 |
| Perrigo (PRGO) | Ireland | $3.614B | 9.16 |
| Haemonetics (HAE) | United States | $3.485B | 15.18 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.459B | 25.51 |
| Envista Holdings (NVST) | United States | $3.066B | 25.48 |
| QuidelOrtho (QDEL) | United States | $2.234B | 15.36 |
| GN Store Nord (GNNDY) | Denmark | $2.150B | 17.81 |
| LeMaitre Vascular (LMAT) | United States | $1.882B | 42.07 |
| AtriCure (ATRC) | United States | $1.599B | 0.00 |
| Neogen (NEOG) | United States | $1.424B | 18.22 |
| AdaptHealth (AHCO) | United States | $1.220B | 12.38 |
| Kestra Medical Technologies (KMTS) | United States | $1.220B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.209B | 27.19 |
| BioLife Solutions (BLFS) | United States | $1.045B | 0.00 |
| InMode (INMD) | Israel | $1.023B | 9.37 |
| Phibro Animal Health (PAHC) | United States | $0.966B | 12.35 |
| Evolus (EOLS) | United States | $0.645B | 0.00 |
| CeriBell (CBLL) | United States | $0.636B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.586B | 0.00 |
| Owens & Minor (OMI) | United States | $0.548B | 4.54 |
| Valneva SE (VALN) | France | $0.516B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.499B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.443B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.437B | 0.00 |
| Surmodics (SRDX) | United States | $0.401B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.354B | 0.00 |
| SNDL (SNDL) | Canada | $0.336B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.325B | 11.95 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.279B | 49.60 |
| Sanara MedTech (SMTI) | United States | $0.274B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.271B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.268B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.266B | 22.47 |
| Cerus (CERS) | United States | $0.247B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.246B | 0.00 |
| ZimVie (ZIMV) | United States | $0.242B | 11.00 |
| Omeros (OMER) | United States | $0.230B | 0.00 |
| Biote (BTMD) | United States | $0.220B | 6.18 |
| Brainsway (BWAY) | Israel | $0.188B | 49.90 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.184B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.180B | 14.51 |
| Quanterix (QTRX) | United States | $0.175B | 0.00 |
| Organigram Global (OGI) | Canada | $0.166B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.165B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 16.72 |
| Jin Medical (ZJYL) | China | $0.129B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.128B | 0.00 |
| Exagen (XGN) | United States | $0.122B | 0.00 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Fonar (FONR) | United States | $0.084B | 10.83 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.075B | 0.00 | |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.067B | 0.00 |
| Zynex (ZYXI) | United States | $0.066B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.065B | 0.00 |
| United Health Products (UEEC) | United States | $0.064B | 0.00 |
| Apyx Medical (APYX) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.052B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.00 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 30.57 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |